Clinicopathological significance of p53 and mdm2 protein expression in human pancreatic cancer

Table 1 Correlation between p53 and mdm2 expression and clinicopathological parameters.

Parameters		No. of patients(n = 59)	Number expressing (%)
			p53(+) (n = 40)	mdm2(+) (n = 17)
Gender	Male	38	25 (65.8)	10 (26.3)
	Female	21	15 (71.4)	7 (33.3)
Age (yr)	<65	47	35 (74.5)	13 (27.7)
	≥65	12	5 (41.7)	4 (33.3)
Site	Head	52	34 (65.4)	16 (30.8)
	Body/tail	7	6 (85.7)	1 (14.3)
TNM stage	I	4	2 (50)	0 (0)
	II	8	4 (50)	0 (0)
	III	42	34 (81)	15 (35.7)
	IV	5	4 (80)	2 (40)
Grade	Well	19	14 (73.7)	4 (21.1)
	Moderate	21	12 (57.1)	9 (42.9)
	Poor	19	14 (73.7)	4 (21.1)